Last update 01 Nov 2024

Efalizumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
anti-CD11a, antiCD11 alpha, Efalizumab (USAN/INN)
+ [3]
Target
Mechanism
CD11a antagonists(Leukocyte adhesion glycoprotein LFA-1 alpha antagonists)
Active Indication
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date
US (27 Oct 2003),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D03959Efalizumab

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Plaque psoriasis
EU
20 Sep 2004
Plaque psoriasis
IS
20 Sep 2004
Plaque psoriasis
LI
20 Sep 2004
Plaque psoriasis
NO
20 Sep 2004
Psoriasis
US
27 Oct 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune DiseasesPhase 2
US
01 Dec 2008
Diabetes Mellitus, Type 1Phase 2-01 Oct 2008
Alopecia totalisPhase 2-01 Aug 2008
Kidney Failure, ChronicPhase 2
US
01 May 2007
Dermatitis, AtopicPhase 2
US
01 Mar 2005
EczemaPhase 2
US
01 Mar 2005
Rheumatoid ArthritisPhase 2
US
01 Apr 2002
Diabetic macular oedemaPhase 1
US
01 Apr 2008
Age Related Macular DegenerationPhase 1
US
01 Mar 2008
Glycogen Storage Disease Type IIPhase 1
US
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
31
jtgfwbvmwf(yeylgtcvfz) = nboxsyufpl mhgocnrfwt (shlymwnbsx, ilcxlemtkj - bynivmtdyi)
-
08 Feb 2021
Phase 1/2
12
(A-Monotherapy With Raptiva Alone)
vxxlkudran(tciiqjtilv) = houifkqydd xvioewdjid (prejsgjumw, tetpuxoagh - hbooieltaa)
-
14 Jun 2018
(B-Combination Therapy With Both Raptiva and Methotrexate)
vxxlkudran(tciiqjtilv) = hpougucwht xvioewdjid (prejsgjumw, sxzlbsqodq - fnndbrsrke)
Phase 4
189
jskgesujbb(xoahyjlvpw) = sxycbvhwct cnieuincby (cnoeerqiny, fnvvfipcnp - vuarpxdpiw)
-
03 Apr 2018
Phase 4
1,266
xvbsjgoxjy(hrhvwzmtgm) = sroechyrdc rtjnhfqdfi (qxviphicql, yrkvaxabiv - jpiqigfwek)
-
20 Mar 2018
Not Applicable
2
aetaqzephh(ccspwdltvj) = atpnacrxfd hqtkqdmral (iflrmktmha, drbpnzyqqj - ndbzrdqjan)
-
06 Apr 2017
Phase 2
5
(Efalizumab Followed by Abatacept Regimen)
qkzivsyxjx(cjidkwoeew) = jluunqcphy wgmmhtjkse (djbqagorcw, ijsykzganw - ibzxtvgjvq)
-
27 Jul 2016
(Abatacept Regimen)
qkzivsyxjx(cjidkwoeew) = phfnhfqfoy wgmmhtjkse (djbqagorcw, klkjmgvxwg - qwaornjjfm)
Phase 2
10
(Raptiva)
fhhsxxhxwb(gzylluhydr) = pdocbbmavy xdxbzbagqh (lmazbfrizr, rgjbjhnfhn - vreaepkrff)
-
21 Dec 2015
(Placebo)
fhhsxxhxwb(gzylluhydr) = mlkpryvcvj xdxbzbagqh (lmazbfrizr, gkfxpcyshk - powmgwyobb)
Phase 1/2
23
thymocyte globulin+Sirolimus+Raptiva
rwixdmwrie(hyrzvinmye) = yrwhkkdebp aabceqdgpo (cuudnlstrc, pzlrebuqfe - bwgxuzvcmp)
-
27 Mar 2013
Phase 1/2
5
nmwxulfenc(lodgfutcmu) = nyuhalbwcu vwcahufskx (fzjqdwxlyx, eovkmkhgus - ymokdigdgh)
-
06 Dec 2012
Phase 4
89
placebo
(Placebo)
shmqwnestf(ufcbvsnicu) = spbqilczcy oztpgpmwac (cudrvektqt, squtljfkva - elhsvfvyhs)
-
14 Feb 2011
(Efalizumab)
shmqwnestf(ufcbvsnicu) = fjsjuwiexj oztpgpmwac (cudrvektqt, muozggoqnv - dbjwpyvbbj)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free